Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,606 public trials 492 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Recruiting

Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma

NCT06216158

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Universitätsklinikum Krems an der Donau Krems, Austria
  • Ordensklinikum Linz Elisabethinen Linz, Austria
  • Landeskrankenhaus Salzburg, Universitätsklinik für Innere Medizin III Salzburg, Austria
  • Klinik Ottakring Wien Vienna, Austria
View all 69 locations
View Trial Details
Recruiting

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

NCT00582621

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Colon Cancer, +36 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

NCT06357754

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +20 more
Locations
  • Local Institution - 0016 Portland, Oregon, United States
  • Ut Southwestern Dallas, Texas, United States
  • Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
  • Local Institution - 0004 Madison, Wisconsin, United States
View Trial Details
Recruiting

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

NCT05366881

Conditions
Adnexal Diseases, Bladder Cancer, Blood Protein Disorders, +96 more
Locations
  • City of Hope Duarte, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • North Georgia Health System Gainesville, Georgia, United States
  • Baptist Floyd New Albany, Indiana, United States
View all 17 locations
View Trial Details

Related conditions